D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 54,613 292 World Ranking 8210 National Ranking 4475

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Cancer and Estrogen receptor. His Breast cancer research is multidisciplinary, incorporating elements of Gynecology and Bioinformatics. His work deals with themes such as Surgery and Pathology, which intersect with Internal medicine.

His Oncology research incorporates elements of Anastrozole, Randomized controlled trial, Oncotype DX, Biomarker and Prospective cohort study. Matthew J. Ellis interconnects Mutation, Cancer research and Exome in the investigation of issues within Cancer. As part of one scientific family, Matthew J. Ellis deals mainly with the area of Estrogen receptor, narrowing it down to issues related to the Endocrinology, and often Estrogen analog and Epidermal growth factor receptor.

His most cited work include:

  • Comprehensive molecular portraits of human breast tumours (7253 citations)
  • Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer (3458 citations)
  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes (2823 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Breast cancer, Internal medicine, Oncology, Cancer and Cancer research. His research in Breast cancer intersects with topics in Chemotherapy and Bioinformatics. His studies in Internal medicine integrate themes in fields like Endocrinology and Gynecology.

His Oncology study combines topics from a wide range of disciplines, such as Neoadjuvant therapy, Clinical trial, Aromatase, Metastatic breast cancer and Endocrine system. His Cancer study frequently links to adjacent areas such as Pathology. His biological study spans a wide range of topics, including Gene, Metastasis, Triple-negative breast cancer, PI3K/AKT/mTOR pathway and Estrogen receptor alpha.

He most often published in these fields:

  • Breast cancer (73.46%)
  • Internal medicine (53.32%)
  • Oncology (43.60%)

What were the highlights of his more recent work (between 2017-2021)?

  • Breast cancer (73.46%)
  • Internal medicine (53.32%)
  • Cancer research (26.07%)

In recent papers he was focusing on the following fields of study:

Matthew J. Ellis spends much of his time researching Breast cancer, Internal medicine, Cancer research, Oncology and Cancer. His Breast cancer research incorporates themes from Chemotherapy and Endocrine system. The study incorporates disciplines such as Immune checkpoint, Proteogenomics, Proteomics, Metastasis and Estrogen receptor alpha in addition to Cancer research.

His Oncology research is multidisciplinary, incorporating perspectives in Fulvestrant, HER2 negative, Docetaxel, Exemestane and Prospective cohort study. His research investigates the link between Cancer and topics such as PI3K/AKT/mTOR pathway that cross with problems in Kinase. In his study, Kinome is strongly linked to Metastatic breast cancer, which falls under the umbrella field of Estrogen receptor.

Between 2017 and 2021, his most popular works were:

  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (685 citations)
  • Long noncoding RNA MALAT1 suppresses breast cancer metastasis (197 citations)
  • Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities. (142 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Breast cancer, Cancer research, Proteomics, Internal medicine and Cancer. His study in Breast cancer is interdisciplinary in nature, drawing from both Immune checkpoint, Microarray analysis techniques and Chemotherapy. The various areas that Matthew J. Ellis examines in his Cancer research study include Aromatase inhibitor, Gene knockdown, Suppressor, Receptor and Metastasis.

His work focuses on many connections between Proteomics and other disciplines, such as Proteogenomics, that overlap with his field of interest in Computational biology, Endometrial cancer, Histone and Druggability. His Internal medicine study frequently draws connections between related disciplines such as Oncology. His studies deal with areas such as Mortality rate and Demography as well as Cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Nature (2012)

6768 Citations

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis;Alison Stopeck.
The New England Journal of Medicine (2004)

4519 Citations

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Joel S. Parker;Michael Mullins;Maggie C.U. Cheang;Samuel Leung.
Journal of Clinical Oncology (2009)

3842 Citations

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Maggie C. U. Cheang;Stephen K Chia;David Voduc;Dongxia Gao.
Journal of the National Cancer Institute (2009)

2522 Citations

The molecular portraits of breast tumors are conserved across microarray platforms

Zhiyuan Hu;Cheng Fan;Daniel S Oh;JS Marron.
BMC Genomics (2006)

1755 Citations

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett.
Journal of the National Cancer Institute (2011)

1553 Citations

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

Matthew J. Ellis;Andrew Coop;Baljit Singh;Louis Mauriac.
Journal of Clinical Oncology (2001)

1507 Citations

Genome remodelling in a basal-like breast cancer metastasis and xenograft

Li Ding;Matthew J C Ellis;Shunqiang Li;David E. Larson.
Nature (2010)

1229 Citations

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard.
The New England Journal of Medicine (2015)

1076 Citations

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

Daniel F. Hayes;Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis.
Clinical Cancer Research (2006)

1074 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Matthew J. Ellis

Charles M. Perou

Charles M. Perou

University of North Carolina at Chapel Hill

Publications: 229

Mitch Dowsett

Mitch Dowsett

Breast Cancer Research Foundation

Publications: 193

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 187

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 168

Giuseppe Viale

Giuseppe Viale

European Institute of Oncology

Publications: 168

Vessela N. Kristensen

Vessela N. Kristensen

Oslo University Hospital

Publications: 154

Anne Lise Børresen-Dale

Anne Lise Børresen-Dale

Oslo University Hospital

Publications: 153

Massimo Cristofanilli

Massimo Cristofanilli

Northwestern University

Publications: 149

Carlos Caldas

Carlos Caldas

University of Cambridge

Publications: 145

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 136

Eric P. Winer

Eric P. Winer

Harvard University

Publications: 130

Ian O. Ellis

Ian O. Ellis

University of Nottingham

Publications: 125

Lajos Pusztai

Lajos Pusztai

Yale University

Publications: 124

Klaus Pantel

Klaus Pantel

Universität Hamburg

Publications: 121

Daniel F. Hayes

Daniel F. Hayes

University of Michigan–Ann Arbor

Publications: 110

Martine Piccart

Martine Piccart

Université Libre de Bruxelles

Publications: 109

Trending Scientists

Zongpeng Li

Zongpeng Li

Tsinghua University

Anatoly V. Zayats

Anatoly V. Zayats

King's College London

Ghenwa Bouhadir

Ghenwa Bouhadir

Paul Sabatier University

Weiwei He

Weiwei He

Food and Drug Administration

Kwang Sun Ryu

Kwang Sun Ryu

University of Ulsan

Qingfeng Dong

Qingfeng Dong

Jilin University

Toshihiro Tanaka

Toshihiro Tanaka

Tokyo Medical and Dental University

Noel J. Buckley

Noel J. Buckley

University of Oxford

Laurinda A. Jaffe

Laurinda A. Jaffe

University of Connecticut Health Center

Jean-Pierre Wigneron

Jean-Pierre Wigneron

University of Bordeaux

Mark Connors

Mark Connors

National Institutes of Health

Hideaki Tahara

Hideaki Tahara

University of Tokyo

Courtenay Frazier Norbury

Courtenay Frazier Norbury

University of Oslo

Myron A. Hofer

Myron A. Hofer

Columbia University

Jeff C. Huffman

Jeff C. Huffman

Harvard University

Keith A. Sharkey

Keith A. Sharkey

University of Calgary

Something went wrong. Please try again later.